ブックタイトル血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

概要

血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

169. Fisher MC, Long SS, Roberts EM, Dunn JM, Balsara RK. Pseudomonas maltophilia bacteremia in childrenundergoing open heart surgery. JAMA 1981; 246:1571?4.170. Stamm WE, Colella JJ, Anderson RL, Dixon RE. Indwelling arterial catheters as a source of nosocomialbacteremia. An outbreak caused by Flavobacterium Species. N Engl J Med 1975; 292:1099?102.171. Weinstein RA, Emori TG, Anderson RL, Stamm WE. Pressure transducers as a source of bacteremia afteropen heart surgery. Report of an outbreak and guidelines for prevention. Chest 1976; 69:338?44.172. Shinozaki T, Deane RS, Mazuzan JE Jr., Hamel AJ, Hazelton D. Bacterial contamination of arterial lines. Aprospective study. JAMA 1983; 249:223?5.173. Solomon SL, Alexander H, Eley JW, et al. Nosocomial fungemia in neonates associated with intravascularpressure-monitoring devices. Pediatr Infect Dis 1986; 5:680?5.174. Weems JJ Jr., Chamberland ME, Ward J, Willy M, Padhye AA, Solomon SL. Candida parapsilosis fungemiaassociated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol 1987;25:1029?32.175. Villarino ME, Jarvis WR, O’Hara C, Bresnahan J, Clark N. Epidemic of Serratia marcescens bacteremia in acardiac intensive care unit. J Clin Microbiol 1989; 27:2433?6.176. Beck-Sague CM, Jarvis WR, Brook JH, et al. Epidemic bacteremia due to Acinetobacter baumannii in fiveintensive care units. Am J Epidemiol 1990; 132:723?33.177. Gillies D, Wallen MM, Morrison AL, Rankin K, Nagy SA, O’Riordan E. Optimal timing for intravenousadministration set replacement. Cochrane Database of Systematic Reviews 2005; Issue 4. Art. No.:CD003588. DOI: 10.1002/14651858.CD003588.pub2.178. Sitges-Serra A, Linares J, Perez JL, Jaurrieta E, Lorente L. A randomized trial on the effect of tubingchanges on hub contamination and catheter sepsis during parenteral nutrition. JPEN J Parenter EnteralNutr 1985; 9:322?5.179. Snydman DR, Donnelly-Reidy M, Perry LK, Martin WJ. Intravenous tubing containing burettes can be safelychanged at 72 hour intervals. Infect Control 1987; 8:113?6.180. Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets forintravenous therapy at 48-vs 72hour intervals. 72 hours is safe and cost-effective. JAMA 1987; 258:1777?81.181. Josephson A, Gombert ME, Sierra MF, Karanfil LV, Tansino GF. The relationship between intravenous fluidcontamination and the frequency of tubing replacement. Infect Control 1985; 6:367?70.182. Melly MA, Meng HC, Schaffner W. Microbiol growth in lipid emulsions used in parenteral nutrition. ArchSurg 1975; 110:1479?81.183. Mershon J, Nogami W, Williams JM, Yoder C, Eitzen HE, Lemons JA. Bacterial/fungal growth in a combinedparenteral nutrition solution. JPEN J Parenter Enteral Nutr 1986; 10:498?502.184. Gilbert M, Gallagher SC, Eads M, Elmore MF. Microbial growth patterns in a total parenteral nutritionformulation containing lipid emulsion. JPEN J Parenter Enteral Nutr 1986; 10:494?7.185. Maki DG, Martin WT. Nationwide epidemic of septicemia caused by contaminated infusion products. IV.Growth of microbial pathogens in fluids for intravenous infusions. J Infect Dis 1975; 131:267?72.186. Bennett SN, McNeil MM, Bland LA, et al. Postoperative infections traced to contamination of an intravenousanesthetic, propofol. N Engl J Med 1995; 333:147?54.187. Arduino MJ, Bland LA, Danzig LE, McAllister SK, Aguero SM. Microbiologic evaluation of needleless andneedle-access devices. Am J Infect Control 1997; 25:377?80.188. Brown JD, Moss HA, Elliott TS. The potential for catheter microbial contamination from a needlelessconnector. J Hosp Infect 1997; 36:181?9.58